According to a new report from Start-Up Nation Central, investments in companies operating in the Israeli Digital Health Sector surpassed $1 billion for the first time in Israel’s history in the first half of 2021. Startup Nation’s medtech field brought in $1.021 billion in the first half of 2021. This is more than twice the $438 million that it raised in the first half of 2020. And the figure is already more than the total amount raised in investment for all of 2020. It also surpasses 2019, the last year before the Coronavirus pandemic affected all markets.
“The first half of 2021 saw investment capital spread out much more evenly among the various Digital Health subsectors,” says Startup Nation Central. “The Big 3 subsectors (Remote Monitoring, Decision Support, Diagnostics) accounted for only 53% of the total amount raised compared to the historical 80%. The Digital Therapeutics subsector exhibited the largest growth, raising $147M, which triples the total amount raised by the subsector in 2020. The investment spree has made it the third most funded subsector after Diagnostics and Decision Support, overtaking Remote Monitoring, which had received a boost of investment in 2020 as a response to the COVID-19 pandemic.”
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
The report also shows that that 2021 has seen a greater diversity in the sources of new capital raised. The new sources came from both within Israel as well as sources outside of the country.
Start-Up Nation Central Digital Health Analyst Lena Rogovin said, “The Israeli Digital Health sector broke the funding record on the back of record global investments, increased maturity of the sector, and reduced focus on COVID-19 solution alongside a greater emphasis on consumer health, as we forecast in our previous reports. We expect this trend to continue in the second half of the year driven by investors’ greater attention to previously overlooked subsectors and an improved understanding of the market needs as a result of recent global exits and large strategic partnerships that provide a benchmark for the entire market, including the Israeli ecosystem.”
